12 February 2021
Transense Technologies plc
("Transense" or "the Company")
Further re. Completion of Capital Reduction
Further to the Company's announcement on 28 January 2021, Transense Technologies plc (AIM: TRT), the developer of specialist sensor systems, announces that the court order and statement of capital relating to the Capital Reduction have now been registered at Companies House. Accordingly, the Capital Reduction is now effective.
Further details on the Capital Reduction were set out in the Company's circular and Notice of AGM dated 23 November 2020.
Transense is due to release interim results for the six months ended 31 December 2020 on Wednesday 17 February 2021 at 7am.
For further information please visit www.transense.com or contact:
| Transense Technologies plc Nigel Rogers (Executive Chairman) Melvyn Segal (CFO) | Via Walbrook PR |
| Allenby Capital (Nominated Adviser and Broker) Jeremy Porter/ George Payne (Corporate Finance) Tony Quirke (Sales and Corporate Broking) | Tel: +44 (0)20 3328 5656 |
| Walbrook PR Tom Cooper/Nick Rome/Nicholas Johnson | Tel: +44 (0)20 7933 8780 Transense@walbrookpr.com |
Notes to Editors:
Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring. Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense 's Tyre Pressure Monitoring System, recently licensed to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal; and a range of intelligent tyre monitoring equipment under the Translogik brand. Target sectors include automotive, aerospace, industrial, green energy, rail and marine.
The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik probes - through leveraging excellence in innovation, know-how in commercialising technologies, industry partnerships and exposure to global growth markets.
Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. www.transense.com
For further information please contact transense@walbrookpr.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
